S&P 500 7,663.43 −1.21%
Nasdaq 26,008.86 −2.60%
S&P/TSX 35,973.45 −0.97%
Apple 348.22 +1.23%
Nvidia 212.21 −4.40%
Microsoft 521.08 −2.23%
Shopify 236.41 −3.48%
Royal Bank 282.78 −0.30%
CAD/USD 0.7140 +0.26%
CLOSED · 23:55 ET
Market ClerkRecap
Thu Oct 22 · markets closed6 signals today103 insider buys this week · $208.8MCIRO short report next: Oct 31The week ahead
PA
INSIDER · IMVT · Immunovant, Inc. · DIRECTOR

Pande Atul

Every open-market transaction filed under this name, Aug 28 to Aug 28.

Filings
1
0 buys · 1 sell
Bought
—
open market, at cost
Sold
$65K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Aug 28IMVTImmunovant, Inc.DirectorSell1,500$43.27$65K−35.5%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.